Monte-G HC Interactions
There are 606 drugs known to interact with Monte-G HC (guaifenesin/hydrocodone), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 213 are major, 391 are moderate, and 2 are minor.
- View all 606 medications that may interact with Monte-G HC
- View Monte-G HC alcohol/food interactions (1)
- View Monte-G HC disease interactions (16)
Most frequently checked interactions
View interaction reports for Monte-G HC (guaifenesin / hydrocodone) and the medicines listed below.
- albuterol
- albuterol
- allopurinol
- allopurinol
- Ambien (zolpidem)
- Ambien (zolpidem)
- amitriptyline
- amitriptyline
- amlodipine
- amlodipine
- amoxicillin
- amoxicillin
- aspirin
- aspirin
- atenolol
- atenolol
- atropine
- atropine
- baclofen
- baclofen
- bisoprolol
- bisoprolol
- cetirizine
- cetirizine
- clopidogrel
- clopidogrel
- gabapentin
- gabapentin
- metformin
- metformin
Monte-G HC alcohol/food interactions
There is 1 alcohol/food interaction with Monte-G HC (guaifenesin / hydrocodone).
Monte-G HC disease interactions
There are 16 disease interactions with Monte-G HC (guaifenesin / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
Report options
QR code containing a link to this page
More about Monte-G HC (guaifenesin / hydrocodone)
- Monte-G HC consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.